Topics

Companies Related to "PARP Inhibition Appears Promising CRPC Questions Remain∨derfield=score∨derval=DESC" [Most Relevant Company Matches] [Advanced Search Results] RSS

18:47 EDT 19th July 2019 | BioPortfolio

Here are the most relevant search results for "PARP Inhibition Appears Promising CRPC Questions Remain∨derfield=score∨derval=DESC" found in our extensive corporate database of over 50,000 company records.

Showing "PARP Inhibition Appears Promising CRPC Questions Remain derfield" Companies 1–25 of 699

Monday 1st July 2019

Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company that is focused on the discovery and development of medicines for chronic liver disease and cancer. Based in China and the United States, the company is advancing a pipeline of small molecule drug candidates for the treatment of non-alcoholic steatohepatitis (NASH) and cancer, across m...


Friday 28th June 2019

Newron Pharmaceutical S.p.A.

Newron (SIX: NWRN) is a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central and peripheral nervous system. The company is headquartered in Bresso near Milan, Italy. Xadago® (safinamide) has received marketing authorization for the treatment of Parkinson’s disease in the European Union, Switzerland, the US, Australia, Canada, Br...

Thursday 27th June 2019

ImmunoGen

ImmunoGen, Inc. develops pharmaceuticals, primarily for the treatment of cancer. The Company's product candidates arecalled tumor-activated prodrugs ("TAPs") and are based on its proprietary immunoconjugate technology platform. Unlike conventional chemotherapeutic agents, TAPs are intended to deliver potent chemotherapy specifically to a tumor. Each TAP immunoconjugate comprises a small-molecule d...


Wednesday 26th June 2019

The Evergreen Market

The Evergreen Market was founded by three dads from Issaquah who met through their daughters being in the Y-princesses YMCA program. They’ve been a leader in the Washington recreational cannabis space since 2014. From outreach events to senior homes, sponsoring a local MMA fighter who advocates for CBD, publishing a how-to cookbook for making infused dishes with proper dosing, and having a p...

Friday 21st June 2019

Textmunication Holdings, Inc.

Based in Silicon Valley, Textmunication Inc. is a leading mobile marketing solutions provider to more than a thousand clients across North America. An early adopter of next-generation text message protocol Rich Communication Services (RCS), the Company currently leverages its proprietary SMS software platform to deliver robust APIs and integrated solutions to a diverse range of end users includin...

Alnylam Biotherapeutics

RNAi (RNA interference) is a natural cellular process of gene silencing that represents one of the most promising and rapidly advancing frontiers in biology and drug development today. Its discovery has been heralded as “a major scientific breakthrough that happens once every decade or so,” and was recognized with the award of the 2006 Nobel Prize for Physiology or Medicine. By harnessi...

Wednesday 12th June 2019

OnKure, Inc.

OnKure, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure's drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenv...

Questionmark

Questionmark assessment technologies are used by organizations worldwide to securely measure knowledge, skills and attitudes for certification, regulatory compliance, workforce learning, channel expertise and higher education. Questionmark's assessment management system provides collaborative, secure authoring of questions and assessments; comprehensive it...

Tuesday 11th June 2019

Tarveda Therapeutics®, Inc.

Tarveda Therapeutics is a clinical stage biopharmaceutical company that is developing and discovering a new class of potent and selective precision oncology medicines for the treatment of patients with solid tumor malignancies. We are developing our proprietary Pentarin® miniature conjugates to enhance the effectiveness of promising anti-cancer payloads...

Monday 3rd June 2019

TransCure bioServices

TransCure bioServices SAS is a European CRO based in France offering pre-clinical in vivo pharmacology fee-for-services to international pharmaceutical, biotech and academic customers. Uniquely designed full human immune system and hu-liver mouse models provide predictive power for drug profiling and smarter drug candidate selection for immuno-oncology, in...

SpringWorks Therapeutics, Inc.

At SpringWorks Therapeutics, a clinical-stage biopharmaceutical company, we are driven to develop life-changing medicines for patients with severe rare diseases and cancer. Since our launch in 2017, we have worked to identify and advance promising science, beginning with our licensed clinical therapies from Pfizer Inc. We pioneer efficient pathways for dru...

Wednesday 22nd May 2019

ControlRad, Inc.

ControlRad is a privately held medical technology company developing innovative products that dramatically reduce the radiation exposure from fluoroscopically guided procedures (FGP) for patients and healthcare professionals. ControlRad’s products are designed to improve safety without compromising image quality or workflow. They include an integrated...

Wednesday 15th May 2019

BioCatch

BioCatch is a digital identity company that delivers AI-driven behavioral biometrics, analyzing human-device interactions to protect users and data. Banks and other enterprises use BioCatch to significantly reduce online fraud and better manage online identity verification, without compromising the user experience. With an unparalleled patent portfolio and...

Monday 6th May 2019

OnKure

OnKure, Inc. is a biopharmaceutical company focused on the discovery and development of targeted small molecule drugs to improve the outcomes of patients afflicted with cancer. OnKure's drug candidates aim to treat patients by targeting malignant cells directly, by working in combination with other small molecule therapies and by priming the tumor microenv...

Thursday 25th April 2019

Avenda Health

Avenda Health is the only image-guided ablation system (pending FDA clearance) that leverages artificial intelligence to treat only the tumor, minimizing the side effects of the treatment on the patient. Unlike other options, this approach has the potential to offer patients a personalized treatment performed in-office using local anesthesia, potentially a...

Thursday 18th April 2019

Surge Private Equity

Surge Private Equity (https://www.SurgePE.com/) is a Dallas-based private equity firm that seeks majority investments in growing businesses with $2-7.5MM of EBITDA. Together with its lending partners, Surge provides entrepreneurs with liquidity and investors with higher yields and greater accessibility through lower investment minimums. Surge primarily inv...

Monday 15th April 2019

Inteliquet

Inteliquet is a leading provider of intelligent technology, insights and expertise that help dramatically to reduce the barriers and time involved in designing and conducting clinical trials and research, from feasibility and site selection to patient screening and matching. We harness vast sets of oncology and patient data to bring a new level of clarity ...

Thursday 28th March 2019

24 Hour Home Care

24 Hour Home Care provides high-quality, customized, professional caregiving services to seniors and individuals with developmental disabilities, allowing them to continue full, active and healthy lifestyles. Founded by David Allerby, Tyner Brenneman-Slay, and Ryan Iwamoto in 2008, 24 Hour Home Care has expanded to 16 locations throughout California, Arizo...

Tuesday 26th March 2019

Vela Diagnostics

Vela Diagnostics is a leading provider of an automated IVD Next–Generation Sequencing (NGS) workflow in the global diagnostics market. Vela’s real-time PCR and NGS applications are available on one integrated Sentosa® platform; this provides a unique ability for the customers to leverage one system for two workflows, while carrying out tests...

Wednesday 27th February 2019

Blackstone Life Sciences

Blackstone Life Sciences is a private investment platform with capabilities to invest across the life-cycle of companies and products within the key life science sectors. By combining scale investments and hands-on operational leadership, Blackstone Life Sciences helps bring to market promising new medicines that improve patients’ lives. In launching ...

Friday 15th February 2019

Health Net, LLC

At Health Net, we believe every person deserves a safety net for their health, regardless of age, income, employment status or current state of health. Founded 40 years ago, we remain dedicated to transforming the health of our community, one person at a time. Today, more than 3,000 Health Net employees, and approximately 85,000 network providers, serve mo...

Thursday 24th January 2019

Good Housekeeping

Founded in 1885, Good Housekeeping (www.goodhousekeeping.com) magazine reaches 25 million readers each month. The Good Housekeeping Research Institute, the consumer product evaluation laboratory of the magazine founded in 1900, is dedicated to improving the lives of consumers and their families through education and product evaluation. Before any advertisement appears in the magazine, it must fi...

Thursday 20th December 2018

PetaGene

PetaGene was founded in Cambridge, the birth place of genomics, to address the rapidly growing data management problems of the genomics industry. PetaGene's software enables compression of huge amounts of genomic data without compromising on access or data quality. The company's products go beyond regular data reduction techniques and have twice been recog...

Tuesday 4th December 2018

ChemomAb

ChemomAb is a clinical stage biopharmaceutical company, specializes in the development of proprietary monoclonal antibodies, directed towards novel targets, for the treatment of fibrotic-inflammatory disorders including NASH as well as orphan indications. The antibodies are designed to treat patients with fibrotic and inflammatory diseases through a novel ...

Wednesday 28th November 2018

TransMed Systems, Inc.

TransMed is a leading provider of technology, insights, and expertise that help harness the power of knowledge to dramatically improve the process of developing, identifying, and matching eligible patients to clinical trials. Powered by a vast oncology data consortium, a powerful clinical trial enablement platform, and people expertise, TransMed believes t...


More From BioPortfolio on "PARP Inhibition Appears Promising CRPC Questions Remain∨derfield=score∨derval=DESC"

Quick Search

Corporate Database Quicklinks